Better quality-of-life questions for adolescents and young adults with cancer

Optimizing Health Related Quality of Life Measurement in Adolescent and Young Adult Oncology: A Promising Solution (PROMIS AYA) - Aim 2

Observational Wake Forest University Health Sciences · NCT06897137

This project will test how adolescents and young adults with cancer (ages 15–39) and their caregivers in the U.S. answer quality-of-life questions so the questions can be improved.

Quick facts

Study typeObservational
Enrollment3000 (estimated)
Ages15 Years and up
SexAll
SponsorWake Forest University Health Sciences Academic / other
Locations1 site (Winston-Salem, North Carolina)
Trial IDNCT06897137 on ClinicalTrials.gov

What this trial studies

This observational project refines PROMIS patient-reported outcome items focused on body image, fertility, and financial burden for adolescents and young adults with cancer. It applies item response theory analyses to test assumptions like unidimensionality and local independence, examines item-level properties including differential item functioning, and supports development of computer-adaptive testing. Participants (AYA cancer patients/survivors, AYA general-population peers, and caregivers) complete surveys and legacy measures to allow creation of short forms and to test convergent validity. The work is coordinated through Wake Forest Baptist Comprehensive Cancer Center with NCI collaboration and is limited to English-speaking participants in the U.S.

Who should consider this trial

Good fit: Ideal participants are English-speaking adolescents and young adults aged 15–39 in the U.S. who were first diagnosed between ages 15–39 (either newly in curative treatment or up to 10 years post-treatment), plus caregivers of eligible AYAs and a comparison group of AYA general-population respondents.

Not a fit: People who are non-English-speaking, live outside the U.S., have only basal cell skin cancer, or are currently receiving hospice care are unlikely to benefit from or be eligible for this work.

Why it matters

Potential benefit: If successful, the improved questionnaires could give clinicians and researchers more accurate, sensitive measures of body image, fertility concerns, and financial burden for young people with cancer.

How similar studies have performed: PROMIS item banks and IRT-based methods are well-established and have been successful in other populations, and this project applies those validated methods to AYA-specific domains.

Eligibility criteria

Show full inclusion / exclusion criteria
AYAs with a cancer history (AYA-C)

Inclusion Criteria:

* Young adults between the ages of 15 to 39 years;
* First diagnosed with cancer during 15 to 39 years of age;
* Able to read and understand English;
* Live in the United States;
* Have a new cancer diagnosis and are receiving curative treatment OR are currently 0 to 10 years post-treatment.

Exclusion Criteria:

* Diagnosed with basal cell skin cancer; or
* Are currently receiving hospice care.

AYAs General Population (AYA-GP)

Inclusion Criteria:

* Young adults between the ages of 15 to 39 years;
* Able to read and understand English; and
* Live in the United States.

Caregivers of AYAs with cancer (AYA-Cg)

Inclusion Criteria:

* 18 years of age or older;
* Able to read and understand English;
* Live in the United States;
* Have a child/ward/partner for whom they have provided care, AND
* Their child/ward/partner is 15 to 25 years of age and meets the other eligibility criteria as an AYA participant with a cancer history (described above).

Where this trial is running

Winston-Salem, North Carolina

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Malignant Solid NeoplasmHematopoietic NeoplasmsLymphatic System Neoplasm
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.